Medical tubing market seen reaching $26.7 billion by 2030

The medical tubing market is projected to grow from $14.12 billion in 2025 to $16.04 billion in 2026, then climb to $26.7 billion by 2030, according to The Business Research Company. Rising respiratory disease cases, more minimally invasive procedures and wider use of disposable medical devices are among the main drivers.

Why it matters: - Medical tubing sits inside a wide range of procedures and devices, from IV therapy and catheters to ventilators and biopharmaceutical systems. - The market’s growth reflects heavier healthcare demand, more infection-control focus and broader use of advanced polymer materials. - The projected rise to $26.7 billion by 2030 points to sustained demand across hospitals, home healthcare and drug manufacturing.

What happened: - The Business Research Company released a medical tubing market study on Aug. 18, 2026. - The report estimates the market at $14.12 billion in 2025 and $16.04 billion in 2026. - The study projects the market will reach $26.7 billion by 2030. - The report also says the market is growing at a 13.5% CAGR from 2025 to 2026 and a 13.6% CAGR through 2030. - A free sample and the full report are available through the company’s sample page and the full market report.

The details: - The report says growth is being driven by higher hospital procedural volumes. - The report cites increasing use of IVs and catheters as another demand driver. - Disposable medical devices are becoming more widely adopted, which supports tubing demand. - Biopharmaceutical manufacturing is expanding and needs specialized tubing. - Advanced polymer materials are improving tubing production. - Forecast growth is tied to minimally invasive medical devices, home healthcare expansion, patient safety priorities and infection control. - The study highlights rising use of specialty polymer tubing as a trend. - Other trends include biocompatible materials, custom-extruded medical tubes, sterile single-use tubing systems, drug delivery applications and chemical- and heat-resistant tubing. - Medical tubing is designed to transport fluids to and from the body and support medical devices. - The tubes are manufactured under sterile conditions to reduce contamination risk. - The report says medical tubing is used in anesthesia and respiratory equipment, IV therapy, catheters, peristaltic pumps and biopharmaceutical labs. - Respiratory disease growth is a key driver because ventilators and related devices rely on medical tubing. - The report points to rising cases of asthma, lung cancer and pulmonary fibrosis, with links to tobacco use, air pollution, allergens and occupational hazards. - The US Centers for Disease Control and Prevention reported tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, while the incidence rate increased from 2.5 to 2.9 per 100,000 people. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region over the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The size of the forecast suggests medical tubing is benefiting from both near-term procedural demand and longer-cycle growth in biopharma and home care. - The shift toward sterile single-use systems and biocompatible materials signals a market that is becoming more regulated and more specialized. - North America’s lead and Asia-Pacific’s faster growth point to a market with mature demand in developed healthcare systems and expansion potential in newer care markets. - The CDC tuberculosis data offers a concrete example of how respiratory disease trends can ripple into device demand.

What’s next: - The Business Research Company says the 2026 edition of its market reports adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report’s outlook suggests continued investment in minimally invasive devices, biopharmaceutical production and infection-control products will shape demand through 2030. - The company lists expert contacts for follow-up questions, including Saumya Sahay and Oliver Guirdham.